small cell lung cancertherapeutical implicationsSerological tumor markers may become widely used as inexpensive and non-invasive methods of cancer detection. Markers of current interest for small cell lung cancer (SCLC) comprise enzymes, peptides, proteins, and carbohydrates. None of the serological ...
Tumor markersP2055LIQUID BIOPSY AND SERUM TUMOR MARKERS IN LUNG CANCER: A REAL-LIFE EXPERIENCEC. Arrigo 1, F.S. Falvella 1, V. Filipazzi 2, N. La Verde 2, M. Panteghini 11Clinical Pathology Unit, ASST Fatebenefratelli-Sacco, Milano, Italy2Oncology Unit, Ospedale Luigi Sacco, ASST Fat...
We investigated whether serum tumor markers (STMs) represent a valuable noninvasive tool to predict epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC) patients. Methods A retrospective analysis was performed for 143 NSCLC patients at the Peking University Internatio...
CancerMargolis ML,Hyzy JB,Schenken LL,et al.Serum tumor markers in non-small cell lung cancer. Cancer . 1994Margolis, et al., " Serum tumor markers in non-small cell lung cancer, " Cancer 73:605-609 (1994).Margolis ML, Hyzy JB, Schenken LL, Schepart BS. Serum tumor markers in ...
The tumor markers were divided into the serum tumor markers and cell tumor markers now for clinical diagnosis.Common form of lung serum tumor markers includecarcinoembryonic antigen,neuron-specific enolase,cytokeratin 19 fragment,squamous cell carcinoma-associated antigen,gastrin releasing peptide fragment,ti...
Non-small cell lung cancer (NSCLC) is the common type of lung cancer, which is the leading cause of cancer death throughout the world. Most patients were diagnosed too late for curative treatment. So, it is necessary to develop a minimal invasive method to identify NSCLC at an early stage...
7. Neuron specific enolase (NSE): a serum marker of small cell lung cancer. 8. Free- β- HCG: specific tumor marker of germ cell tumor, which is closely related to the degree of tumor deterioration; 9. Prostate specific antigen (PSA): tumor markers for screening prostate cancer in men ...
Small-cell lung cancer (SCLC), an aggressive neuroendocrine tumor with early dissemination and dismal prognosis, accounts for 15–20% of lung cancer cases and∼200,000 deaths each year. Most cases are inoperable, and biopsies to investigate SCLC biology are rarely obtainable. Circulating tumor c...
Application of non-small cell lung cancer pleural effusion tumor markerApplication of non-small cell lung cancer pleural effusion tumor markerThe invention belongs to the field of biological sample detection and discloses an application of a non-small cell lung cancer pleural effusion tumor marker. ...
Small cell lung cancer (SCLC) represents 15% of lung cancers and is characterized by early dissemination, development of chemoresistance and a poor prognosis. A host of diverse drugs failed invariably and its mechanisms of global chemoresistance have not